Effects of losartan compared with atenolol on lipids in patients with hypertension and left ventricular hypertrophy: The Losartan Intervention for Endpoint reduction in hypertension study Academic Article uri icon

Overview

MeSH Major

  • Antihypertensive Agents
  • Hypertension
  • Hypertrophy, Left Ventricular
  • Lipid Metabolism
  • Losartan

abstract

  • Losartan blunted the decrease in HDL cholesterol during antihypertensive treatment in the LIFE study. Higher intreatment HDL cholesterol was associated with fewer composite endpoints and may partly explain the better outcome of losartan-based treatment.

publication date

  • March 2009

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1097/HJH.0b013e32831daf96

PubMed ID

  • 19262226

Additional Document Info

start page

  • 567

end page

  • 74

volume

  • 27

number

  • 3